⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BHC News
Bausch Health Companies Inc
Bausch Health's Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage(R) Non-Surgical System
accessnewswire.com
BHC
BHC
Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025
accessnewswire.com
BHC
DRRX
BHC
DRRX
Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide Gel), Now Available Through Public Drug Plans of Quebec and Saskatchewan
accessnewswire.com
BHC
BHC
Le traitement pour l’acné vulgaire de Bausch Health, Canada Inc., (Pr)CABTREO(MC) (gel de phosphate de clindamycine, d’adapalène et de peroxyde de benzoyle), est maintenant couvert par les régimes publics du Québec et de la Saskatchewan
accessnewswire.com
BHC
BHC